C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.405 AUD -6.64% Market Closed
Market Cap: 156.1m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Cyclopharm Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cyclopharm Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
R
RSH
IPD
COH
OIL
EMV

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Total Liabilities & Equity
AU$64.1m
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
23%
R
Respiri Ltd
ASX:RSH
Total Liabilities & Equity
AU$6.2m
CAGR 3-Years
-12%
CAGR 5-Years
44%
CAGR 10-Years
-5%
ImpediMed Ltd
ASX:IPD
Total Liabilities & Equity
AU$47m
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
12%
Cochlear Ltd
ASX:COH
Total Liabilities & Equity
AU$2.7B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
13%
Optiscan Imaging Ltd
ASX:OIL
Total Liabilities & Equity
AU$15.6m
CAGR 3-Years
10%
CAGR 5-Years
34%
CAGR 10-Years
34%
EMvision Medical Devices Ltd
ASX:EMV
Total Liabilities & Equity
AU$24m
CAGR 3-Years
31%
CAGR 5-Years
36%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
64.1m AUD

Based on the financial report for Jun 30, 2024, Cyclopharm Ltd's Total Liabilities & Equity amounts to 64.1m AUD.

What is Cyclopharm Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
23%

Over the last year, the Total Liabilities & Equity growth was 30%. The average annual Total Liabilities & Equity growth rates for Cyclopharm Ltd have been 6% over the past three years , 21% over the past five years , and 23% over the past ten years .

Back to Top